Radient Pharmaceuticals Corporation fka RXPC

[dcspka]

Guardiangel, Very good point.

A small firm like GCDx cannot quickly ramp up to promote the Lung Cancer test on a global scale without Radient's distribution network. Nor can William Gartner on his own fund the validation studies.

It is Provista in conjunction with Fortis/SRL that is making both of these events happen, and very soon now to coincide with the Breast Cancer Study results coming shortly.

As I have said many times, the Aussies are just caretaker officers appointed by The Man behind the Curtain. They got the job on a temporary basis because they were available on short notice. They will see something for their trouble, and then go away leaving Provista to expand everything on an international basis.

Look for Provista to bring us their "new and exciting website" shortly as promised.